On March 12, 2024, the Second Circuit affirmed the dismissal of federal False Claims Act claims against pharmaceutical distributor McKesson Corporation and its related subsidiaries , which were.
A federal appeals court on Tuesday revived a lawsuit by a whistleblower who accused McKesson of providing drug pricing tools to doctors to induce them to purchase drugs from the company.. -March 12, 2024 at 09:21 am EDT
- MarketScreener
Orthopedic surgeons and patients say the waiting lists are so long in Quebec that it's not surprising that more patients and doctors are going private.